UNICORNS: Uveitis in Childhood Prospective National Cohort Study
NCT05385757 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2024-10-04
Summary
Childhood uveitis (inflammation inside the eye) is an uncommon disorder that carries the risk of blindness. Inadequate treatment of active inflammation has been shown to be related to a poor outcome. There has been no population-based, prospective longitudinal study of all-cause childhood uveitis, with resultant limitations in the evidence base used to counsel affected families, balance treatment decisions, or plan further research. The aim of the study is to describe the characteristics of childhood-onset uveitis and describe outcomes. The investigators shall also aim to identify the socio-demographic, clinical, biological and treatment-related determinants of outcome. Early (1-2 years following diagnosis) outcomes will be described in the first instance: However, through the creation of a national inception cohort, the investigators shall enable longer-term studies of outcome for affected children and families. There will be no change to routine clinical care.
Conditions
- Uveitis
Sponsors & Collaborators
-
National Institute for Health Research, United Kingdom
collaborator OTHER_GOV -
Institute of Child Health
lead OTHER
Principal Investigators
-
Ameenat L Solebo · University College London (UCL) Great Ormond Street Institute of Child Health
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-22
- Primary Completion
- 2025-12-31
- Completion
- 2026-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Immune Indicators of Uveitis
NCT00089739 ·Status: COMPLETED
-
Leflunomide to Treat Uveitis
NCT00001863 ·Status: COMPLETED ·Phase: PHASE2
-
Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis
NCT05388838 ·Status: RECRUITING ·Phase: NA
-
Treatment FOr Corticosteroid Dependent UveitiS
NCT06258915 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
NCT00331331 ·Status: COMPLETED
-
Analysis of Eye Tissue
NCT00001224 ·Status: COMPLETED
-
Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis
NCT00043667 ·Status: COMPLETED ·Phase: PHASE2
-
Screening for NEI Clinical Studies
NCT00001734 ·Status: COMPLETED
-
Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
NCT00070759 ·Status: COMPLETED ·Phase: PHASE2
-
Uveitis Gene-Expression Profiling
NCT00874471 ·Status: COMPLETED
-
The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma
NCT00943982 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study
NCT01164085 ·Status: COMPLETED ·Phase: PHASE1
-
Metagenomics for Ocular Inflammation
NCT06974162 ·Status: RECRUITING
-
Outcome of Treatment of Uveitis With Biologic Drugs in Resistant Cases Vogt-koyanagi-Harada Disease
NCT05349747 ·Status: UNKNOWN
-
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
NCT00468871 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
NCT05523765 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Daclizumab/Denileukin Diftitox to Treat Uveitis
NCT00326508 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Thalidomide in Chronic Uveitis
NCT00314665 ·Status: TERMINATED ·Phase: PHASE4
-
A Clinical Trial of Infliximab for Uveitis
NCT00273390 ·Status: COMPLETED ·Phase: NA
-
Abatacept in the Treatment of Uveitis
NCT01279954 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis
NCT01162070 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
NCT01032915 ·Status: TERMINATED ·Phase: PHASE3
-
A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis
NCT03634475 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a
NCT00508040 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
NCT01090310 ·Status: TERMINATED ·Phase: PHASE3